Protein kinase C-θ is an early survival factor required for differentiation of effector CD8+ T cells

Journal of Immunology

Volumn 175, Issue 8, 2005, Pages 5126-5134

  Barouch Bentov, Rina ^a   Lemmens, Edward E ^a   Hu, Junru ^a   Janssen, Edith M ^a   Droin, Nathalie M ^a   Song, Jianxun ^a   Schoenberger, Stephen P ^a   Altman, Amnon ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE C THETA; STRESS ACTIVATED PROTEIN KINASE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TRANSGENIC MOUSE;

EID: 26844551590     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.8.5126     Document Type: Article

References (40)

1. + T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18: 275-308.
2. + T cell responses: it's all downhill after their prime. Nat. Immunol. 3: 601-602.
3. Griffiths, G. M. 1995. The cell biology of CTL killing. Curr. Opin. Immunol. 7: 343-348.
4. Oehen, S., and K. Brduscha-Riem. 1998. Differentiation of naive CTL to effector and memory CTL: correlation of effector function with phenotype and cell division. J. Immunol. 161: 5338-5346.
5. Bachmann, M. F., M. Barner, A. Viola, and M. Kopf. 1999. Distinct kinetics of cytokine production and cytolysis in effector and memory T cells after viral infection. Eur. J. Immunol. 29: 291-299.
6. Kaech, S. M., E. J. Wherry, and R. Ahmed. 2002. Effector and memory T-cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2: 251-262.
7. Kaech, S. M., S. Hemby, E. Kersh, and R. Ahmed. 2002. Molecular and functional profiling of memory CD8 T cell differentiation. Cell 111: 837-851.
8. + effector and memory T cell generation. Nat. Immunol. 4: 835-842.
9. Monks, C. R., B. A. Freiberg, H. Kupfer, N. Sciaky, and A. Kupfer. 1998. Three-dimensional segregation of supramolecular clusters in T cells. Nature 395: 82-86.
10. Monks, C. R. F., H. Kupfer, I. Tamir, A. Barlow, and A. Kupfer. 1997. Selective modulation of protein kinase C-θ during T-cell activation. Nature 385: 83-86.
11. Sun, Z., C. W. Arendt, W. Ellmeier, E. M. Schaeffer, M. J. Sunshine, L. Gandhi, J. Annes, D. Petrzilka, A. Kupfer, P. L. Schwartzberg, et aln. 2000. PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytes. Nature 404: 402-407.
12. 2+ mobilization and NFAT cell activation in primary mouse T cells. J. Exp. Med. 197: 1525-1535.
13. van Stipdonk, M. J., E. E. Lemmens, and S. P. Schoenberger. 2001. Naive CTLs require a single brief period of antigenic-stimulation for clonal expansion and differentiation. Nat. Immunol. 2: 423-429.
14. L and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 15: 445-455.
15. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063-1066.
16. Matzinger, P. 1991. The JAM test: a simple assay for DNA fragmentation and cell death. J. Immunol. Methods 145: 185-192.
17. + T cell help. J. Exp. Med. 186: 65-70.
18. + T lymphocyte responses. Nat. Immunol. 4: 361-365.
19. Marsden, V. S., and A. Strasser. 2003. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu. Rev. Immunol. 21: 71-105.
20. Marrack, P., and J. Kappler. 2004. Control of T cell viability. Annu. Rev. Immunol. 22: 765-787.
21. Lord, J. D., B. C. McIntosh, P. D. Greenberg, and B. H. Nelson. 1998. The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc. J. Immunol. 161: 4627-4633.
22. L expression and cell survival. Eur. J. Immunol. 29: 1158-1167.
23. Van Parijs, L., Y. Refaeli, J. D. Lord, B. H. Nelson, A. K. Abbas, and D. Baltimore. 1999. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity 11: 281-288.
24. Akbar, A. N., and M. Salmon. 1997. Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol. Today 18: 72-76.
25. Mitchell, T., J. Kappler, and P. Marrack. 1999. Bystander virus infection prolongs activated T cell survival. J. Immunol. 162: 4527-4535.
26. Vella, A. T., S. Dow, T. A. Potter, J. Kappler, and P. Marrack. 1998. Cytokine-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95: 3810-3815.
27. Kamakura, S., T. Moriguchi, and E. Nishida. 1999. Activation of the protein kinase ERK5/BMK1 by receptor tyrosine kinases: identification and characterization of a signaling pathway to the nucleus. J. Biol. Chem. 274: 26563-26571.
28. Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98: 13681-13686.
29. Berg-Brown, N. N., M. A. Gronski, R. G. Jones, A. R. Elford, E. K. Deenick, B. Odermatt, D. R. Littman, and P. S. Ohashi. 2004. PKCθ signals activation versus tolerance in vivo. J. Exp. Med. 199: 743-752.
30. Marsland, B. J., T. J. Soos, G. Spath, D. R. Littman, and M. Kopf. 2004. Protein kinase Cθ is critical for the development of in vivo T helper Th2 cell but not Th1 cell responses. J. Exp. Med. 200: 181-189.
31. Salek-Ardakani, S., T. So, B. S. Halteman, A. Altman, and M. Croft. 2004. Differential regulation of Th2 and Th1 lung inflammatory responses by PKCθ. J. Immunol. 173: 6440-6447.
32. Bertolotto, C., L. Maulon, N. Filippa, G. Baier, and P. Auberger. 2000. PKC-θ and ε promote T cell survival by a Rsk-dependent phosphorylation and inactivation of BAD. J. Biol. Chem. 275: 37246-37250.
33. Villalba, M., P. Bushway, and A. Altman. 2001. PKCθ mediates a selective T cell survival signal via phosphorylation of BAD. J. Immunol. 166: 5955-5963.
34. Hildeman, D. A., Y. Zhu, T. C. Mitchell, P. Bouillet, A. Strasser, J. Kappler, and P. Marrack. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity 16: 759-767.
35. + T cell-mediated antiviral immunity. J. Exp. Med. 195: 801-810.
36. Putcha, G. V., S. Le, S. Frank, C. G. Besirli, K. Clark, B. Chu, S. Alix, R. J. Youle, A. LaMarche, A. C. Maroney, et al. 2003. JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron 38: 899-914.
37. Ley, R., K. Balmanno, K. Hadfield, C. Weston, and S. J. Cook. 2003. Activation of the ERK1/2 signaling pathway promotes phosphorylation and proteasome-dependent degradation of the BH3-only protein, Bim. J. Biol. Chem. 278: 18811-18816.
38. EL causing its phosphorylation and turnover. J. Biol. Chem. 279: 8837-8847.
39. Blattman, J. N., J. M. Grayson, E. J. Wherry, S. M. Kaech, K. A. Smith, and R. Ahmed. 2003. Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo. Nat. Med. 9: 540-547.
40. D'Souza, W. N., and L. Lefrancois. 2003. IL-2 is not required for the initiation of CD8 T cell cycling but sustains expansion. J. Immunol. 171: 5727-5735.